Prostate Neuroendocrine Carcinoma — Trials

Prostate Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04754425	Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer	terminated	Phase 2	11	M.D. Anderson Cancer CenterOTHER	1	Feb 6, 2026	clinicaltrials
NCT03649841	Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer	terminated	Phase 2	10	University of WashingtonOTHER	1	Oct 26, 2023	clinicaltrials